149 Views
Sunday Poster Session
Category: Biliary/Pancreas
Supisara Tintara, MD
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, MA, United States
Non-idiopathic AP (n=435) | Idiopathic AP (n=142) | p-value | |
Demographics | |||
Age (SD) | 52.7 (16.5) | 49.3 (14.7) | 0.022 |
Body mass index, BMI (SD) | 27.6 (7.41) | 27.3 (7.51) | 0.683 |
Female (%) | 200 (46.0%) | 79 (55.6%) | 0.057 |
Race (%) | 0.218 | ||
Caucasian | 292 (68.9%) | 105 (76.6%) | |
African American | 110 (25.9%) | 27 (19.7%) | |
Other | 22 (5.19%) | 5 (3.65%) | |
History of pancreatitis (%) | 164 (37.7%) | 86 (60.6%) | < 0.001 |
Congestive heart failure (%) | 16 (3.69%) | 2 (1.41%) | 0.266 |
Stroke (%) | 19 (4.38%) | 5 (3.52%) | 0.840 |
Chronic obstructive pulmonary disease, COPD (%) | 56 (12.9%) | 14 (9.86%) | 0.420 |
Liver disease (%) | 35 (8.05%) | 19 (13.4%) | 0.084 |
Diabetes mellitus (%) | 69 (15.9%) | 40 (28.2%) | 0.002 |
Chronic kidney disease (%) | 16 (3.68%) | 17 (12.0%) | 0.001 |
Alcohol use (%) | 195 (45.1%) | 24 (17.1%) | < 0.001 |
Tobacco use (%) | 125 (29.0%) | 38 (27.5%) | 0.870 |
Charlson comorbidity index (%) | 0.433 | ||
0 | 121 (27.8%) | 34 (23.9%) | |
1-2 | 156 (35.9%) | 57 (40.1%) | |
3-5 | 114 (26.2%) | 32 (22.5%) | |
6 and above | 44 (10.1%) | 19 (13.4%) | |
Vital signs and baseline labs | |||
Heart rate (SD) | 84.9 (18.3) | 81.4 (17.6) | 0.051 |
Temperature (SD) | 98.3 (0.99) | 98.1 (1.13) | 0.060 |
Respiratory rate (SD) | 17.9 (3.54) | 17.6 (2.15) | 0.229 |
Creatinine (SD) | 1.03 (1.56) | 1.02 (0.76) | 0.949 |
Hematocrit (SD) | 39.4 (17.2) | 37.1 (6.03) | 0.022 |
White blood cell count (SD) | 11.1 (5.79) | 9.44 (4.45) | < 0.001 |
Lactate (SD) | 1.94 (1.43) | 2.38 (1.49) | 0.152 |
Lipase (SD) | 2191 (3874) | 965 (3059) | < 0.001 |
Alanine transaminase (SD) | 185 (298) | 45.1 (76.5) | < 0.001 |
Aspartate aminotransferase (SD) | 198 (450) | 50.4 (79.2) | < 0.001 |
Alkaline phosphatase (SD) | 145 (117) | 107 (112) | 0.001 |
Total billirubin (SD) | 1.84 (4.74) | 0.65 (0.91) | < 0.001 |
Triglyceride (SD) | 429 (1268) | 834 (1758) | 0.091 |
Severity of pancreatitis | |||
BISAP (%) | 0.055 | ||
0 | 186 (46.2%) | 73 (57.9%) | |
1-2 | 198 (49.1%) | 50 (39.7%) | |
3 and above | 19 (4.71%) | 3 (2.38%) | |
Atlanta Criteria (%) | 0.324 | ||
Mild | 312 (73.9%) | 112 (80.0%) | |
Moderate | 94 (22.3%) | 23 (16.4%) | |
Severe | 16 (3.79%) | 5 (3.57%) | |
Pleural effusion (%) | 84 (21.2%) | 14 (10.0%) | 0.005 |
Pancreas necrosis (%) | 102 (25.6%) | 26 (18.7%) | 0.129 |
Studies | |||
MRI (%) | 104 (24.1%) | 21 (14.8%) | 0.027 |
X-ray (%) | 242 (55.9%) | 79 (55.6%) | 1.000 |
Ultrasound (%) | 225 (52.0%) | 60 (42.3%) | 0.056 |
CT (%) | 208 (48.0%) | 77 (54.2%) | 0.237 |
ERCP (%) | 145 (33.5%) | 12 (8.45%) | < 0.001 |
EGD (%) | 33 (7.67%) | 16 (11.3%) | 0.249 |